Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-02-20 @ 12:33 PM
Study NCT ID:
NCT03830905
Status:
COMPLETED
Last Update Posted:
2020-11-16
First Post:
2019-01-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI
Sponsor:
PHARMENTERPRISES LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ARI-XC221-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |